142 related articles for article (PubMed ID: 18089462)
1. Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition.
Ehrenreich H; Bartels C; Sargin D; Stawicki S; Krampe H
J Ren Nutr; 2008 Jan; 18(1):146-53. PubMed ID: 18089462
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research.
Sargin D; Friedrichs H; El-Kordi A; Ehrenreich H
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):573-94. PubMed ID: 21619868
[TBL] [Abstract][Full Text] [Related]
3. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis.
Ehrenreich H; Fischer B; Norra C; Schellenberger F; Stender N; Stiefel M; Sirén AL; Paulus W; Nave KA; Gold R; Bartels C
Brain; 2007 Oct; 130(Pt 10):2577-88. PubMed ID: 17728357
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin and neuroprotection: a therapeutic perspective.
Milano M; Collomp R
J Oncol Pharm Pract; 2005 Dec; 11(4):145-9. PubMed ID: 16595066
[TBL] [Abstract][Full Text] [Related]
5. The use of erythtropoietin in cerebral diseases.
Cotena S; Piazza O; Tufano R
Panminerva Med; 2008 Jun; 50(2):185-92. PubMed ID: 18607342
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin (rHuEPO): more than just the correction of uremic anemia.
Buemi M; Aloisi C; Cavallaro E; Corica F; Floccari F; Grasso G; Lasco A; Pettinato G; Ruello A; Sturiale A; Frisina N
J Nephrol; 2002; 15(2):97-103. PubMed ID: 12018644
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin prevents the death of mice during cerebral malaria.
Kaiser K; Texier A; Ferrandiz J; Buguet A; Meiller A; Latour C; Peyron F; Cespuglio R; Picot S
J Infect Dis; 2006 Apr; 193(7):987-95. PubMed ID: 16518761
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of erythropoietin on acute spinal cord injury. An experimental study on a rat model.
Kontogeorgakos VA; Voulgaris S; Korompilias AV; Vekris M; Polyzoidis KS; Bourantas K; Beris AE
Arch Orthop Trauma Surg; 2009 Feb; 129(2):189-94. PubMed ID: 18309506
[TBL] [Abstract][Full Text] [Related]
9. The role of erythropoietin in neuroprotection: therapeutic perspectives.
Grasso G; Sfacteria A; Meli F; Passalacqua M; Fodale V; Buemi M; Giambartino F; Iacopino DG; Tomasello F
Drug News Perspect; 2007 Jun; 20(5):315-20. PubMed ID: 17878959
[TBL] [Abstract][Full Text] [Related]
10. Experimental models of acute renal failure and erythropoietin: what evidence of a direct effect?
Sturiale A; Campo S; Crascì E; Aloisi C; Buemi M
Ren Fail; 2007; 29(3):379-86. PubMed ID: 17497457
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis.
Bartels C; Späte K; Krampe H; Ehrenreich H
Ther Adv Neurol Disord; 2008 Nov; 1(3):193-206. PubMed ID: 21180577
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin and treatment of non-anemic conditions--cardiovascular protection.
Fliser D; Haller H
Semin Hematol; 2007 Jul; 44(3):212-7. PubMed ID: 17631185
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin: novel approaches to neuroprotection in human brain disease.
Ehrenreich H; Aust C; Krampe H; Jahn H; Jacob S; Herrmann M; Sirén AL
Metab Brain Dis; 2004 Dec; 19(3-4):195-206. PubMed ID: 15554415
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria.
Wiese L; Hempel C; Penkowa M; Kirkby N; Kurtzhals JA
Malar J; 2008 Jan; 7():3. PubMed ID: 18179698
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.
Sirén AL; Fasshauer T; Bartels C; Ehrenreich H
Neurotherapeutics; 2009 Jan; 6(1):108-27. PubMed ID: 19110203
[TBL] [Abstract][Full Text] [Related]
16. [Erythropoietin: indications and measurement].
Klein E; Georges A; Brossaud J; Bosredon Kd; Bordenave L; Corcuff JB
Ann Biol Clin (Paris); 2009; 67(5):505-15. PubMed ID: 19789122
[TBL] [Abstract][Full Text] [Related]
17. Intranasal erythropoietin therapy in nervous system disorders.
Genc S; Zadeoglulari Z; Oner MG; Genc K; Digicaylioglu M
Expert Opin Drug Deliv; 2011 Jan; 8(1):19-32. PubMed ID: 21143002
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice.
Yoshimi M; Maeyama T; Yamada M; Hamada N; Fukumoto J; Kawaguchi T; Kuwano K; Nakanishi Y
Respirology; 2008 Sep; 13(5):639-45. PubMed ID: 18713087
[TBL] [Abstract][Full Text] [Related]
19. Novel applications of recombinant erythropoietin.
Sharples EJ; Thiemermann C; Yaqoob MM
Curr Opin Pharmacol; 2006 Apr; 6(2):184-9. PubMed ID: 16483842
[TBL] [Abstract][Full Text] [Related]
20. To give or not to give recombinant EPO to anemia endangered cancer patients.
Sulkowska M; Wincewicz A; Chabowska A; Kanczuga-Koda L; Szymanska M; Koda M; Witkowska E; Sulkowski S
Prague Med Rep; 2006; 107(3):281-9. PubMed ID: 17385400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
